Yüklüyor......
Antenatal Intracellular Concentrations of Tenofovir Diphosphate (TFV-DP) and Emtricitabine Triphosphate, and Associations between TFV-DP and Severe Adverse Pregnancy Outcomes: IMPAACT-PROMISE (1077BF) Trial
BACKGROUND: In the PROMISE trial, tenofovir disoproxil fumarate (TDF) use was associated with moderate or severe adverse pregnancy/neonatal outcomes. This study characterized tenofovir-diphosphate (TFV-DP) and emtricitabine-triphosphate (FTC-TP) concentrations in dried blood spots (DBS), and assesse...
Kaydedildi:
| Yayımlandı: | J Acquir Immune Defic Syndr |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7409985/ https://ncbi.nlm.nih.gov/pubmed/31929405 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000002247 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|